Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ALKEM LABORATORIES NATCO PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 13.3 37.5 35.6% View Chart
P/BV x 3.5 6.5 53.5% View Chart
Dividend Yield % 0.6 1.0 57.1%  

Financials

 NATCO PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
ALKEM LABORATORIES
Mar-23
NATCO PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs8473,625 23.4%   
Low Rs5022,835 17.7%   
Sales per share (Unadj.) Rs148.4970.1 15.3%  
Earnings per share (Unadj.) Rs39.284.2 46.6%  
Cash flow per share (Unadj.) Rs48.2110.2 43.7%  
Dividends per share (Unadj.) Rs5.5050.00 11.0%  
Avg Dividend yield %0.81.5 52.7%  
Book value per share (Unadj.) Rs267.1756.4 35.3%  
Shares outstanding (eoy) m182.47119.57 152.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.53.3 136.5%   
Avg P/E ratio x17.238.4 44.8%  
P/CF ratio (eoy) x14.029.3 47.7%  
Price / Book Value ratio x2.54.3 59.1%  
Dividend payout %14.059.4 23.6%   
Avg Mkt Cap Rs m123,049386,207 31.9%   
No. of employees `000NANA-   
Total wages/salary Rs m4,86721,314 22.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,071115,993 23.3%  
Other income Rs m1,2852,161 59.5%   
Total revenues Rs m28,356118,153 24.0%   
Gross profit Rs m9,11715,065 60.5%  
Depreciation Rs m1,6383,104 52.8%   
Interest Rs m1451,074 13.5%   
Profit before tax Rs m8,61913,048 66.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4662,980 49.2%   
Profit after tax Rs m7,15310,068 71.0%  
Gross profit margin %33.713.0 259.3%  
Effective tax rate %17.022.8 74.5%   
Net profit margin %26.48.7 304.4%  
BALANCE SHEET DATA
Current assets Rs m30,00386,064 34.9%   
Current liabilities Rs m6,83137,071 18.4%   
Net working cap to sales %85.642.2 202.7%  
Current ratio x4.42.3 189.2%  
Inventory Days Days6333 194.8%  
Debtors Days Days11567 172.0%  
Net fixed assets Rs m26,57137,245 71.3%   
Share capital Rs m365239 152.7%   
"Free" reserves Rs m48,37390,208 53.6%   
Net worth Rs m48,73890,447 53.9%   
Long term debt Rs m00-   
Total assets Rs m56,574124,541 45.4%  
Interest coverage x60.413.2 459.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.9 51.4%   
Return on assets %12.98.9 144.2%  
Return on equity %14.711.1 131.8%  
Return on capital %18.015.6 115.2%  
Exports to sales %014.6 0.0%   
Imports to sales %10.20-   
Exports (fob) Rs mNA16,916 0.0%   
Imports (cif) Rs m2,772NA-   
Fx inflow Rs m17,25616,916 102.0%   
Fx outflow Rs m2,7724,190 66.2%   
Net fx Rs m14,48412,727 113.8%   
CASH FLOW
From Operations Rs m8,49116,825 50.5%  
From Investments Rs m-4,7711,128 -422.8%  
From Financial Activity Rs m-3,630-17,608 20.6%  
Net Cashflow Rs m208416 50.0%  

Share Holding

Indian Promoters % 49.7 56.7 87.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 24.4 102.3%  
FIIs % 13.7 8.5 161.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 43.3 116.3%  
Shareholders   207,571 65,184 318.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs ALKEM LABORATORIES Share Price Performance

Period Natco Pharma ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -2.11% -1.18% 1.18%
1-Month -3.19% -0.99% -0.75%
1-Year 72.80% 52.26% 61.82%
3-Year CAGR 4.96% 21.70% 18.16%
5-Year CAGR 10.96% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.